tadalafil has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angielski, S; Audzeyenka, I; Kulesza, T; Myślińska, D; Piwkowska, A; Rachubik, P; Rogacka, D; Szrejder, M | 1 |
| Choudhury, GG; Feliers, D; Gorin, Y; Kasinath, BS; Lee, HJ; Mariappan, MM; Sataranatarajan, K | 1 |
2 other study(ies) available for tadalafil and Diabetic Nephropathies
| Article | Year |
|---|---|
Inhibition of phosphodiesterase 5A by tadalafil improves SIRT1 expression and activity in insulin-resistant podocytes.
Topics: AMP-Activated Protein Kinases; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetic Nephropathies; Glucose; Humans; Hyperglycemia; Insulin; Insulin Resistance; Podocytes; Sirtuin 1; Tadalafil | 2023 |
Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes.
Topics: AMP-Activated Protein Kinases; Animals; Calcium; Carbolines; Diabetic Nephropathies; Extracellular Matrix; Gene Expression Regulation; Glucose; Hydrogen Sulfide; Kidney; Mechanistic Target of Rapamycin Complex 1; Mice; Multiprotein Complexes; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphodiesterase 5 Inhibitors; Phosphorylation; Podocytes; Polyribosomes; Rats; Signal Transduction; Tadalafil; TOR Serine-Threonine Kinases | 2015 |